Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

An interdisciplinary research team involving the German Center for Infection Research (DZIF) has identified two antiviral ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet ...

Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping of ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet ...

But with Britain’s authorization this week of Merck’s new drug molnupiravir, and a cash infusion into antiviral R&D, the outlook for these treatments is getting much brighter. Unlike vaccines ...

Hospitalized flu patients given the antiviral drug oseltamivir (Tamiflu) are less likely to die in the hospital, be released ...

The antiviral baloxavir significantly reduced household transmission of influenza compared with placebo. The drug showed consistent effects across age groups, virus types, and countries ...

Researchers from Liverpool School of Tropical Medicine have helped uncover how ticks mount a defense against a deadly virus ...

A new study published in the journal of BMC Nephrology revealed that kidney disease (KD) caused by an infection with the ...